REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL)
Clinical trial NCT04218825 · TERMINATED
Trial details
- NCT number
- NCT04218825
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-29
- Primary completion
- 2023-04-04
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.